112 related articles for article (PubMed ID: 12064188)
1. [Oral anticoagulants combined with aspirin in the prolonged treatment after acute coronary syndrome].
Di Pasquale G; Biancoli S; Cerè E; Parlangeli R
Ital Heart J Suppl; 2002 May; 3(5):495-501. PubMed ID: 12064188
[TBL] [Abstract][Full Text] [Related]
2. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
[TBL] [Abstract][Full Text] [Related]
3. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiovascular events after acute coronary syndrome.
Wallentin L
Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
[TBL] [Abstract][Full Text] [Related]
5. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulation after myocardial infarction.
Hurlen M; Arnesen H
Herz; 2008 Feb; 33(1):38-43. PubMed ID: 18273576
[TBL] [Abstract][Full Text] [Related]
7. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
[TBL] [Abstract][Full Text] [Related]
8. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
[TBL] [Abstract][Full Text] [Related]
9. [Role of low-molecular-weight heparin in acute coronary syndromes].
Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
Denardo SJ; Davis KE; Tcheng JE
Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
[TBL] [Abstract][Full Text] [Related]
12. Long-term subcutaneous and oral anticoagulants after acute coronary syndromes.
Verheugt FW
Rev Port Cardiol; 2003; 22(7-8):1011-5. PubMed ID: 14587169
[TBL] [Abstract][Full Text] [Related]
13. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
14. Combined antithrombotic therapy for acute coronary syndrome.
Gawaz M; Müller I; Besta F
Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.
Atar S; Cannon CP; Murphy SA; Rosanio S; Uretsky BF; Birnbaum Y
Am Heart J; 2006 May; 151(5):976.e1-6. PubMed ID: 16644315
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Anand SS; Yusuf S
JAMA; 1999 Dec; 282(21):2058-67. PubMed ID: 10591389
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
19. Reducing cardiac events after acute coronary syndromes.
Granger CB; Weaver WD
Rev Cardiovasc Med; 2004; 5 Suppl 5():S39-46. PubMed ID: 15619614
[TBL] [Abstract][Full Text] [Related]
20. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study.
Ariesen MJ; Tangelder MJ; Lawson JA; Eikelboom BC; Grobbee DE; Algra A;
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):154-9. PubMed ID: 15996602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
